scholarly journals Efficacy, safety, and tolerability of ipragliflozin in Asian patients with type 2 diabetes mellitus and inadequate glycemic control with metformin: Results of a phase 3 randomized, placebo‐controlled, double‐blind, multicenter trial

2015 ◽  
Vol 7 (3) ◽  
pp. 366-373 ◽  
Author(s):  
Chieh‐Hsiang Lu ◽  
Kyung Wan Min ◽  
Lee‐Ming Chuang ◽  
Satoshi Kokubo ◽  
Satoshi Yoshida ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glycemic Control ◽  
Multicenter Trial ◽  
Phase 3 ◽  
Double Blind ◽  
Asian Patients ◽  
Inadequate Glycemic Control

Economic simulation of canagliflozin and sitagliptin treatment outcomes in patients with type 2 diabetes mellitus with inadequate glycemic control

2014 ◽  
Vol 18 (2) ◽  
pp. 113-125 ◽  
Author(s):  
Marie-Hélène Lafeuille ◽  
Amanda Melina Grittner ◽  
Jonathan Gravel ◽  
Robert A Bailey ◽  
Silas Martin ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glycemic Control ◽  
Treatment Outcomes ◽  
Economic Simulation ◽  
Inadequate Glycemic Control

scholarly journals Effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus and inadequate glycemic control

2017 ◽  
Vol 61 (2) ◽  
pp. 188-192 ◽  
Author(s):  
Miriam Méndez-del Villar ◽  
Esperanza Martínez-Abundis ◽  
Rafael O. Preciado-Márquez ◽  
Manuel González-Ortiz
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glycemic Control ◽  
Inadequate Glycemic Control

Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study

Pharmateca ◽  
2020 ◽  
Vol 12_2020 ◽  
pp. 38-48
Author(s):  
A.M. Mkrtumyan Mkrtumyan ◽  
S.V. Vorobyev Vorobyev ◽  
A.R. Volkova Volkova ◽  
N.V. Vorokhobina Vorokhobina ◽  
◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Clinical Study ◽  
Glycemic Control ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Randomized Clinical Study

Linagliptin improves glycemic control after 1 year as add-on therapy to basal insulin in Asian patients with type 2 diabetes mellitus

2015 ◽  
Vol 31 (3) ◽  
pp. 503-512 ◽  
Author(s):  
Wayne H.-H. Sheu ◽  
Sung Woo Park ◽  
Yan Gong ◽  
Sabine Pinnetti ◽  
Sudipta Bhattacharya ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glycemic Control ◽  
Basal Insulin ◽  
Asian Patients
Sign in / Sign up

Export Citation Format

Share Document